Institutional investors purchased a net $108.2 thousand shares of THOR during the quarter ended December 2014 and now own 96.40% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MILLENNIUM MANAGEMENT LLC Bought 739.0 Thousand shares of Thoratec Corp
ANTIPODEAN ADVISORS LLC Bought 658.0 Thousand shares of Thoratec Corp
T. ROWE PRICE ASSOCIATES, INC. Bought 644.7 Thousand shares of Thoratec Corp